BIXT OTC
Bioxytran, Inc.
1W: +13.3%
1M: +13.3%
3M: -4.8%
YTD: -66.8%
1Y: -66.3%
3Y: -88.9%
5Y: -88.0%
$0.02
+0.00 (+5.75%)
Weekly Expected Move ±14.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2022-01-14
Earliest Filing
2026-02-17
Latest Filing
partner: 6
target: 2
supplier: 1
customer: 1
investor: 1
acquirer: 1
Counterparties (Filed by BIXT)
12 relationshipsCompanies named in BIXT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Bioxytran, Inc. | BIXT | supplier | Owner of intellectual property and manufacturer supplying the Initial Product. | 2026-02-17 | View |
| Khoury Medical LTD | — | customer | Distributor desirous to commercialize the Initial Product into their designed client. | 2026-02-17 | View |
| NDPD Pharma, Inc. | — | target | Target company acquired 100% of its outstanding shares by Bioxytran, Inc. | 2025-04-03 | View |
| Pharmalectin, Inc. | — | partner | Original licensor of the PLM patent rights transferred via NDPD Pharma, Inc. | 2025-04-03 | View |
| Walleye Opportunities Master Fund Ltd | — | investor | Purchaser of the Convertible Note and party to the Debt Modification Agreement Amendment. | 2025-01-22 | View |
| Bioxytran, Inc. | BIXT | acquirer | Acquired 100% of NDPD Pharma, Inc. for $15.85M in stock | 2024-10-29 | View |
| NDPD Pharma, Inc. | — | target | Target company whose 100% equity was sold to Bioxytran, Inc. | 2024-10-29 | View |
| Pharmalectin, Inc. | — | partner | Holds a license agreement with NDPD Pharma, Inc. | 2024-10-29 | View |
| Bioxytran, Inc. | BIXT | partner | Partner forming a Joint Venture for UOC development and distribution. | 2024-07-17 | View |
| The Heme Foundation | — | partner | Investor contributing capital to fund the Joint Venture. | 2024-07-17 | View |
| NDPD Pharma, Inc. | — | partner | Manufacturer developing the prototype and managing manufacturing for the Joint Venture. | 2024-07-17 | View |
| BIOXYTRAN, INC. | BIXT | partner | Issuer of the convertible note | 2022-01-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-11 | Other Events; Exhibits | View | |
| 2026-03-13 | Material Modification to Rights of Security Holders; Departure/Election of Directors; Appointment of | View | |
| 2026-03-02 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-17 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-02-11 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-05 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-12-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-03 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-01-22 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-01-13 | Non-Reliance on Previously Issued Financial Statements; Financial Statements and Exhibits | View | |
| 2025-01-10 | Other Events; Financial Statements and Exhibits | View | |
| 2024-10-29 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2024-08-20 | Material Modification to Rights of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2024-07-17 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-04-19 | Material Modification to Rights of Security Holders; Departure/Election of Directors; Appointment of | View | |
| 2023-08-24 | Other Events; Financial Statements and Exhibits | View | |
| 2023-06-12 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2023-03-07 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2022-12-14 | Other Events; Financial Statements and Exhibits | View | |
| 2022-12-08 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR